text:
CPI Antitrust Chronicle Nov 2014 (2)
- Stephany Jefferson
- 3 years ago
- Views:
1 CPI Antitrust Chronicle Nov 2014 (2) Good Luck Post-Actavis: Current State of Play on Payfor-Delay Settlements Seth Silber, Jonathan Lutinski, & Ryan Maddock Wilson Sonsini Goodrich & Rosati Competition Policy International, Inc Copying, reprinting, or distributing this article is forbidden by anyone other than the publisher or author.
2 Good Luck Post-Actavis: Current State of Play on Payfor-Delay Settlements Seth Silber, Jonathan Lutinski, & Ryan Maddock 1 I. INTRODUCTION Chief Justice Roberts statement good luck to the district courts in his dissent in FTC v. Actavis was certainly prophetic. 2 Since the Court s issuance of that decision in June 2013, the district courts have been dragged into numerous additional cases more than a dozen cases are currently pending and more than a half dozen decisions have come down with rulings providing a broad spectrum of interpretations as to what the Court meant by a large and unexplained payment. The U.S. Federal Trade Commission ( FTC ), which brought the Actavis case, has added further layers of complexity to pharmaceutical companies trying to understand the post-actavis landscape. On September 8, 2014, the FTC brought its first pay-for-delay case since it filed the Actavis case back in January 2009 a case against AbbVie that also includes sham litigation claims and has launched at least three significant investigations during The FTC also, changing tack after more than a decade, is now pursuing disgorgement in pay-for-delay cases, although the dissenting votes of the two Republican Commissioners in the AbbVie case may indicate a lack of uniformity on this issue, and perhaps indicate some break in the lock-step bipartisan support pay-for-delay cases have enjoyed at the FTC since the late 1990 s. This article examines the current quagmire in the courts, the FTC s recent activities, and finally explores growing interest outside the United States in getting into the pay-for-delay fray. II. WHAT IS A LARGE AND UNEXPLAINED PAYMENT AND HOW DOES ONE PLEAD IT? This fall, Judge Peter Sheridan in the District of New Jersey issued two significant opinions in the pay-for-delay arena. 3 Up until this point, district courts had split on whether Actavis applies only to reverse payments of cash. 4 Judge Sheridan offered a third approach to the 1 Seth Silber is a partner in Wilson Sonsini Goodrich & Rosati's Washington, D.C., office, previously served at the FTC as an advisor to former Chairman Jon Leibowitz, and investigated and litigated pharmaceutical patent settlement challenges while at the FTC. Jonathan Lutinski is a senior associate in the firm's Washington, D.C., office, and also previously served at the FTC as a staff attorney in the agency's Health Care Division reviewing, investigating, and litigating pharmaceutical patent settlement challenges. Ryan Maddock is an associate in the firm s Washington, D.C., office. 2 FTC v. Actavis, Inc., 133 S. Ct. 2223, at 2245 (U.S. 2013) (Roberts, J., Dissenting). 3 In re Lipitor Antitrust Litig., 2014 U.S. Dist. LEXIS (D.N.J. 2014); In re Effexor XR Antitrust Litig., 2014 U.S. Dist. LEXIS (D.N.J. 2014). 4 Compare In re Nexium Esomeprazole Antitrust Litig., 2014 U.S. Dist. LEXIS , at *75 (D. Mass. Sept. 4, 2014) ( unlawful reverse payments are not limited to monetary payments ) with In re Lamictal Direct Purchaser Antitrust Litig., 2014 U.S. Dist. LEXIS 9257, at *22 (D.N.J. Jan. 24, 2014) ( the Supreme Court considered a reverse payment to involve an exchange of money ). 2
3 binary framework set forth in previous decisions. Specifically, he concluded that while nonmonetary payments could constitute reverse payments under Actavis, a complaint must demonstrate a reliable cash value of the non-monetary payment 5 and dismissed the Lipitor and Effexor complaints for failing to do so. These decisions and their implications are discussed in more detail below. A. Lipitor In Lipitor, direct purchaser plaintiffs filed suit against Pfizer and Ranbaxy for allegedly entering into a pay-for-delay settlement with respect to Pfizer s blockbuster cholesterol drug, Lipitor (atorvastatin). 6 According to plaintiffs, Ranbaxy agreed to take a later entry date under the settlement in exchange for the following payments from Pfizer to Ranbaxy: (1) a sweetheart agreement to dismiss Pfizer s damages claims against Ranbaxy (likely worth hundreds of millions of dollars) in unrelated patent litigation (the Accupril II litigation) for a token payment of $1 million; and (2) foreign patent litigation settlements permitting Ranbaxy to launch generic Lipitor in at least 11 non-u.s. markets prior to patent expiration. On September 12, 2014, Judge Sheridan dismissed direct purchasers complaint with prejudice. The court found that Actavis was not restricted to cash payments, but that any nonmonetary payment alleged must be converted to a reliable estimate of its monetary value so that it may be analyzed against the Actavis factors such as whether it is large once the subtraction of legal fees and other services provided by generics occurs. 7 For the payment alleged through Pfizer s agreement to dismiss damages in the Accupril II litigation, plaintiffs generally argued that the non-monetary payment could be the same amount as the bond posted in the patent litigation ($200 million) or it could be the difference in the brand s gross sales ($525 million to $70 million) with and without a generic competitor. However, the court found that these estimates were insufficient, as plaintiffs never attempted to value this non-monetary payment to a reliable measure of damages through a risk-adjusted lost profits analysis. Similarly, for foreign market licenses, the court determined that the complaint lack[ed] any foundation to estimate the cash value of the alleged licenses granted in other countries. 8 Because the complaint failed to provide a reliable foundation showing a cash value of the non-monetary payment, its reverse payment allegations were implausible. The court also noted that plaintiffs failed to consider, or even address, the fact that the payments (even if clearly pled) could have constituted saved litigation costs. According to the court, the agreement settled three U.S. patent infringement litigations and 23 foreign legal actions, so the saved litigation costs could have been in the hundreds of millions of dollars. Plaintiffs failure to attempt to properly value the alleged reverse payments, including the subtraction of any saved litigation costs, made any analysis of whether such payments were large impossible. 5 In re Lipitor Antitrust Litig., 2014 U.S. Dist. LEXIS , at *65. 6 Indirect purchaser plaintiffs also filed suit and, in a separate, later-issued opinion, Judge Sheridan dispatched their claims for similar reasons. 7 Id. at Id. at 72. 3
4 In response to Judge Sheridan s decision, direct purchaser plaintiffs filed a motion to amend the judgment to permit them leave to file an amended complaint. 9 B. Effexor In Effexor, direct purchaser plaintiffs filed suit against Wyeth and Teva for allegedly entering into a pay-for-delay settlement with respect to Effexor XR (venlafaxine hydrochloride), an anti-depressant drug. According to plaintiffs, Teva agreed to accept a later generic entry date under the settlement in exchange for Wyeth s promise to refrain from marketing an authorized generic product during Teva s first 180-days on the market (a no-ag agreement ). On October 7, 2014, similar to his Lipitor decision, Judge Sheridan dismissed plaintiffs pay-for-delay allegations with prejudice. 10 While Judge Sheridan found that the no-ag agreement alleged in Effexor did have value, plaintiffs did not convert it to a specific value using a reliable method. Specifically, plaintiffs asserted that the no-ag payment was worth over $500 million by: (1) claiming that Teva would realize about double the volume of generic sales at significantly higher, supra-competitive prices, 11 and (2) that, for Paxil (a similarly sized drug), another generic firm told the FDA that the presence of an authorized generic cost the company approximately $400 million during its 180-day exclusivity period. The court, however, found that plaintiffs $500 million calculation based on these facts to be vague and amorphous. 12 In addition, the court noted that the question of whether there is a reverse payment involved more than just an analysis of the no-ag agreement. To analyze a payment, one must: (1) value any consideration flowing from the patentee to the claimed infringer, which may take forms other than cash; (2) deduct from that payment the patent holder s avoided litigation costs; and (3) deduct from that payment the value of goods, services, or other consideration provided by the claimed infringer to the patent holder as part of the same transaction (or linked transactions). The resulting net payment is otherwise unexplained and hence an unlawful reverse payment. Here, in addition to failing to reliably calculate the value of the no-ag promise, plaintiffs failed to set forth a reliable foundation for valuing Wyeth s saved litigation costs or the royalty payments paid by Teva to Wyeth. Because plaintiffs did not reliably value the payment under the court s three-step analysis, the court could not determine whether it was reverse (i.e., whether the resulting net payment flowed from alleged infringer to patent holder), whether it was large, or whether it was unexplained. On October 21, 2014, direct purchasers filed a motion asking Judge Sheridan to reconsider his decision to dismiss plaintiffs complaint in Effexor, and allow them to re-plead. 13 The crux of plaintiffs motion for reconsideration is that it was a clear error of law for Judge Sheridan to dismiss plaintiffs complaint under a novel pleading standard that the judge 9 Motion to Amend Judgment, In re Lipitor Antitrust Litig., 2014 U.S. Dist. LEXIS (D.N.J. 2014). 10 Judge Sheridan, however, allowed plaintiffs Walker-Process claim to proceed. 11 In re Effexor XR Antitrust Litig., 2014 U.S. Dist. LEXIS , at * Id. at * Motion to Reconsider, In re Effexor XR Antitrust Litig., 2014 U.S. Dist. LEXIS (D.N.J. 2014). 4
5 announced after the complaint was filed with prejudice. Plaintiffs asserted that they could set forth specific allegations valuing the no-ag agreement even under the court s heightened pleading standard, and claimed to do so in their proposed amended complaint, which was attached to their motion for reconsideration. C. Implications As a result of Judge Sheridan s decisions in Lipitor and Effexor, we expect that plaintiffs, in the future, will include significant detail in their complaints regarding the method by which they are calculating the cash value of any non-monetary payment. For example, in their motion for reconsideration in Effexor, plaintiffs spent over 20 paragraphs in their proposed amended complaint on valuing the alleged non-monetary reverse payment the no-ag clause in an attempt to calculate the cash value of the non-monetary payment using an industry-reliable method. 14 In particular, if other district courts adopt Judge Sheridan s pleading standard, plaintiffs may even be inclined to engage economists or other experts in preparing their complaints to help bolster key valuation allegations on alleged payments through non-monetary settlement provisions. Moreover, given that on November 19, 2014 the Third Circuit heard the oral argument on the Lamictal appeal concerning whether a no-ag agreement can be a reverse payment under Actavis it will also be interesting to see whether the panel will rule on Judge Sheridan s proposed pleading standard in its forthcoming opinion. While the issue is not directly before the Third Circuit, it could opine more broadly on what is required to properly allege a payment under Actavis, as it will be the first Circuit court to issue a decision on this issue. Clients and practitioners alike should stay apprised on continued developments in the direct purchaser plaintiffs motions for leave to re-plead in Lipitor and Effexor as well as the Third Circuit s forthcoming decision in Lamictal. III. FTC HAS BEEN INVIGORATED POST-ACTAVIS After years of waiting for the Supreme Court to weigh in on the pay-for-delay debate, the Court s decision in FTC v. Actavis has invigorated the FTC s enforcement efforts. The Actavis ruling certainly did not give the FTC everything it wanted, as the Court rejected the FTC s preferred presumption of illegality standard that had been set forth by the Third Circuit in K- Dur. 15 However, the Court s rejection of the scope of the patent test favored by several circuits, and expression of concern about patent settlements that contained large and unexplained payments, certainly left the FTC feeling emboldened post-actavis to investigate and challenge settlements. The FTC s foray back into the federal courts in the AbbVie suit reflects the FTC s continued skepticism regarding side-deal arrangements. The FTC filed its September 8, 2014 complaint against AbbVie, Abbott, Unimed, Besins, and Teva in the Eastern District of 14 Id. at In re K-Dur Antitrust Litig., 686 F.3d 197, at 218 (3d Cir. 2012) ( the finder of fact must treat any payment from a patent holder to a generic patent challenger who agrees to delay entry into the market as prima facie evidence of an unreasonable restraint of trade ). 5
6 Pennsylvania. The decision to file the complaint was a 3-2 decision, with Commissioners Wright and Ohlhausen dissenting. The case involves the same drug (Androgel) as in the Actavis case. The complaint alleges that, as trial approached in the AbbVie/Teva Androgel patent litigation, AbbVie entered into a pay-for-delay settlement with Teva to prevent Teva from winning the patent litigation and opening up the generic market. While the complaint s pay-fordelay allegations are heavily redacted, it appears that the compensation was in the form of a side deal namely a product supply agreement for Teva to serve as the authorized generic for AbbVie s TriCor product. 16 The complaint alleges that the authorized generic agreement enabled Teva to compete before independent generic entry is expected, 17 and suggests that Teva got a far higher split of profits than is typical in these sorts of deals. The complaint is also novel in that it alleges that AbbVie pursued sham litigation against Teva and Perrigo, asserting infringement of its 894 patent even though Teva and Perrigo s formulations were clearly outside of the literal scope of the 894 patent and did not infringe. Nearly 14 pages of the total 40 pages in the complaint focus on sham litigation which indicates that the sham claims are of significant importance to the FTC. This case marks the first ever FTC challenge to Hatch-Waxman litigation on sham grounds, although this is an area that the FTC has previously probed. Focusing back on the pay-for-delay allegations, the agreement at issue does not raise any particularly novel issues. The FTC and private plaintiffs have challenged numerous sidedeal arrangements over the past decade and a half. What is of note in AbbVie is a new standard set forth by the FTC that is novel, and not reflected in the Court s Actavis decision. The new standard is as follows: If the generic receives anything from the brand that it could not obtain as a result of winning the patent litigation, it is a reverse payment under Actavis. 18 While this standard has appeared in other private suits and some academic works, the Court in Actavis certainly did not set forth a standard along these lines and no district court since then has endorsed or offered an opinion on whether this standard is consistent with Actavis. It is also quite noteworthy that the Commission vote in the AbbVie suit was 3-2 with Republican Commissioners Ohlhausen and Wright voting against filing the complaint. All prior FTC pay-for-delay consents and suits since the late 1990s were brought on a bi-partisan basis, and Ohlhausen and Wright have supported various recent FTC amicus briefs stating that no-ag agreements constitute compensation. It is unclear why they dissented in this instance as they did not issue dissenting statements when the complaint issued. One potential area of divergence, which could be at least part of the rationale for the dissenting votes, is that the AbbVie complaint seeks disgorgement. Prior FTC pay-for-delay complaints did not seek disgorgement, 19 and 16 Complaint at 120, FTC v. AbbVie, Inc., 2:14-cv-05151, (E.D. Pa. 2014). 17 Id. at See Id. at 124 ( The TriCor authorized generic deal was something Teva could not have obtained had it won the AndroGel patent infringement litigation. Even if Teva had prevailed in the AndroGel litigation, it would not have secured a right to sell an authorized generic version of TriCor. ). 19 The FTC complaint in its Cephalon litigation did not seek disgorgement, although the FTC did later amend its position in that case. Complaint, FTC v. Cephalon, Inc., 551 F. Supp. 2d 21 (D.D.C. 2008). 6
7 Commissioners Ohlhausen and Wright have expressed concern over the use of this tool except in a few narrow circumstances. 20 As far as the pipeline for new FTC challenges following the AbbVie suit, the Commission appears to be dedicating significant resources to investigating settlements. Following the Actavis decision, Chairwoman Ramirez testified before the Senate Judiciary Committee in July 2013 stating: The Supreme Court s decision in Actavis confirms that [reverse payment] settlements harm consumers and competition, and the Commission will continue to aggressively prosecute these anticompetitive settlements. 21 Additional statements from FTC officials at the time further indicated that the FTC would be reviewing prior patent settlement filings to find appropriate cases for challenge. In the wake of these statements, there are a number of publicly disclosed FTC investigations that have emerged over the last year. 22 As part of these investigations, the FTC has issued broad subpoenas, sought investigational hearings of numerous party witnesses, and taken an aggressive position on subpoena compliance in particular with regard to privilege claims. It remains to be seen whether any of these investigations will ripen into litigation. The FTC is busy with three ongoing federal court litigations. In addition to the AbbVie case, the FTC is back in discovery in the Actavis case following remand to the district court in Georgia, and the ongoing Cephalon case in federal court in Philadelphia could end up in trial following the court s oral argument on summary judgment that took place on November 6, Thus, while the FTC waited for years for a Circuit split to emerge, which ultimately resulted in the Actavis decision, it now is proceeding post-actavis with a significant number of litigations and investigations. Companies thus need to remain cognizant about whether their settlements could lead them into an investigation and the courts, while at the same time keeping their eye on private plaintiffs, as discussed above, who likewise remain very active in challenging patent settlements. IV. PATENT SETTLEMENT INVESTIGATIONS GO GLOBAL While the focus on pay-for-delay settlements began in the United States, interest in such agreements has gone global in recent years as international antitrust enforcers have increasingly focused on pharmaceutical patent settlements a trend that undoubtedly will 20 See Statement of Commissioner Maureen K. Ohlhausen Dissenting from the Commission s Decision to Withdraw its Policy Statement on Monetary Equitable Relief in Competition Cases, FTC File No. P (July 31, 2012) available at Joshua D. Wright, The Federal Trade Commission and Monetary Remedies, Remarks at the 18th Annual Competition Law and Policy Workshop, (July 19, 2013) available at 21 Pay-for-Delay Deals: Limiting Competition and Costing Consumers Before the S. Judiciary Comm, 113th Cong. 1 (July 23, 2013) (statement of Edith Ramirez) available at 22 Press reports have noted certain of these investigations. See, e.g., David McLaughlin, U.S. Steps Up Probes of Deals to Block Generic Drugs, BLOOMBERG (June 23, 2014) available at 23/u-s-steps-up-probes-of-deals-to-block-generic-drugs.html. 7
8 continue. Global pharmaceutical companies need to be mindful of antitrust risk, both in and outside the United States, as they negotiate and enter into these agreements. A. European Commission Since 2009, the European Commission ( EC ) has closely monitored pharmaceutical patent settlements. In July 2014, the EC handed down its largest penalty related to a pay-fordelay settlement when it imposed a U.S $449 million fine on Servier for abusing its dominance by entering into settlements that the EC believed kept generic versions of Perindopril, a blood pressure medication, off the market. 23 The EC also imposed U.S. $120.2 million worth of fines on the five generic firms involved in the agreements. The Servier case is not the first time the EC has investigated patent settlements. In 2013 it fined Lundbeck and various generic firms $195.5 million 24 and Johnson & Johnson and Novartis $22.4 million 25 because of pay-for-delay agreements; however, the Perindopril case was the EC s most aggressive case yet. Not only did the EC impose its largest pay-for-delay fine to date, Servier was also the first time the EC investigated a pharmaceutical patent settlement under a dominance standard. The Johnson & Johnson and Lundbeck cases, on the other hand, were brought under the EC s authority to regulate restrictive agreements. By using both the restrictive agreement and dominance standards, which is akin to bringing a claim under both Sections 1 and 2 of the Sherman Act, the EC has signaled that it will continue to challenge pharmaceutical patent settlements. B. Canada Until recently, Canada was not viewed as a country that was playing a role in investigating or challenging pharmaceutical patent settlements. However, at a recent conference on global pharmaceutical antitrust issues, John Pecman, Canada s Commissioner of Competition, indicated that Canada will pursue criminal cases predicated on reverse-payment settlements in certain circumstances. 26 No other country to date has indicated that they view such settlements as raising criminal antitrust implications. Pecman explained that the Competition Bureau, Canada s antitrust enforcers, would be more inclined to commence an inquiry under [Canada s] criminal provision in three circumstances: (1) patent settlements that include conduct with respect to markets or products that are not the focus of the patent litigation, (2) patent settlements that include conduct beyond the scope of the patent, or (3) patent settlements where there is direct or circumstantial evidence that indicates that the settlement is a vehicle for a naked restraint on competition. 23 Melissa Lipman, 3 Key Facts from the EU s Latest Pay-For-Delay Case, LAW360, (July 15, 2014) available at 24 Kathryn Brenzel, EU Fines Lundbeck $125.6M in Pay-For-Delay Probe, LAW360, (June 19, 2013) available at 25 Stewart Bishop, J&J, Novartis Fined $22.4M over Pay-For-Delay Deal, LAW360, (Dec. 10, 2013) available at 26 John Pecman, Canadian Commissioner of Competition, Remarks at the Global Antitrust Institute Conference: Global Antitrust Challenges for the Pharmaceutical Industry, (Sept. 23, 2104) available at 8
9 He further explained that settlements where a generic agreed to enter beyond the expected expiry date of the patent in exchange for a payment or where the evidence suggest[s] that [the] payment was strictly to delay or prevent entry would likely lead to criminal investigations. Pecman also indicated that the Bureau would encourage regulatory changes designed to make it easier to monitor, and ultimately challenge, pharmaceutical patent settlements. He stated that the Bureau would like Canada to adopt a settlement notification system similar to the one in the United States, saying that it would would furnish the Bureau with substantive information about settlement agreements and enhance [its] ability to address potentially anticompetitive agreements. C. India This summer India s competition authority, the Competition Commission of India ( CCI ), began investigating two sets of patent settlements between brand and generic firms. 27 The CCI s analysis of these and other pharmaceutical patent settlements will likely mirror that of the FTC. In 2012, the CCI entered into a Memorandum of Understanding with the FTC and U.S. Department of Justice ( DOJ ) that promised to increase coordination and communication between the agencies; additionally, FTC staff has served as advisors to help the CCI develop its antitrust policy. 28 Considering the FTC s experience with patent settlements, and their history of working closely with the CCI, it is likely that India will apply similar standards as the FTC when investigating patent settlement agreements. D. Other Countries Likely to Follow Suit As so-called pay-for-delay issues continue to attract more attention, additional countries will invariably begin opening their own investigations. In fact, several countries have already taken actions on agreements that, in antitrust enforcers minds, were designed to delay generic entry. Both the Administrative Council for Economic Defense ( CADE ) Brazil s competition authority and the French Competition Authority ( FCA ) have recently issued fines against pharmaceutical companies that offered pharmacies and distributors discounts that allegedly were designed to hinder generic adoption. 29 Additionally, in February 2014, the Australian Competition and Consumer Commission filed an antitrust suit against Pfizer for similar 27 India Enters Pay-for-Delay Fray: CCI Investigating Pharmaceutical Patent Settlements, WSGR, (Aug. 12, 2014) available at CCI.htm; CCI to Scan Drug Patent Settlements, LiveMint, (Aug. 3, 2014) available at 28 FTC and DOJ Sign Memorandum of Understanding With Indian Competition Authorities, Federal Trade Commission (September 27, 2012) available at 29 Global Convergance on Pay-for-Delay settlements, BRISTOWS, (Oct. 16, 2014) available at 9
10 conduct. 30 While the facts of these cases are not analogous to a traditional pay-for-delay case, the alleged anticompetitive effect, delayed generic entry, is identical. Companies should expect that France, Brazil, Australia, and many other countries may soon open their own pharmaceutical patent settlement investigations. 30 Dan Prochilo, Australia Hits Pfizer with Antitrust Suit Over Lipitor, LAW360, (Feb. 13, 2014) available at 10
EC s Preliminary Pharmaceutical Sector Report: An Aggressive Review of Industry Conduct
FEBRUARY 2009, RELEASE TWO EC s Preliminary Pharmaceutical Sector Report: An Aggressive Review of Industry Conduct Susan A. Creighton & Seth C. Silber Wilson, Sonsini, Goodrich and Rosati EC s PreliminaryMore information
CLIENT MEMORANDUM. I. The Basics. June 18, 2013
CLIENT MEMORANDUM FTC v. Actavis: Supreme Court Rejects Bright Line Tests for Reverse Payment Settlements; Complex Questions Remain in Structuring Pharmaceutical Patent Infringement Settlements June 18,More information
Reverse-payment patent settlements in the pharmaceutical industry: An analysis of US antitrust law and EU competition law
Reverse-payment patent settlements in the pharmaceutical industry: An analysis of US antitrust law and EU competition law By Michael Clancy,* Damien Geradin** and Andrew Lazerow*** In the pharmaceuticalMore information
Federal Trade Commission
Federal Trade Commission Antitrust Analysis of Reverse Payment Settlements After Actavis: Three Questions and Proposed Answers Remarks of Joshua D. Wright Commissioner, Federal Trade Commission at theMore information
GOVERNMENT PROSECUTIONS AND QUI TAM ACTIONS DISTRICT OF COLUMBIA OFFICIAL CODE DIVISION I. GOVERNMENT OF DISTRICT. TITLE 2. GOVERNMENT ADMINISTRATION. CHAPTER 3B. OTHER PROCUREMENT MATTERS. SUBCHAPTERMore information
Antitrust Issues in Reverse Payment Settlements Federal Trade Commission v. Actavis, Inc. et al., A Case Study By Amanda Creedon
Antitrust Issues in Reverse Payment Settlements Federal Trade Commission v. Actavis, Inc. et al., A Case Study By Amanda Creedon I. INTRODUCTION Drug manufacturers often spend millions on research andMore information
More Uncertainty: What s The Difference Between a Claim and a Theory?
The AIPLA Antitrust News A Publication of the AIPLA Committee on Antitrust Law October 2010 More Uncertainty: What s The Difference By Steven R. Trybus and Sara Tonnies Horton 1 The United States CourtMore information
Providing key policy setters and decision makers in the global health sector with unique and transformational insights into healthcare dynamics derived from granular analysis of information. IMPACT OFMore information
Pay-for-Delay: How Drug Company Pay-Offs Cost Consumers Billions. An FTC Staff Study January 2010. Federal Trade Commission ftc.
Pay-for-Delay: How Drug Company Pay-Offs Cost Consumers Billions An FTC Staff Study January 2010 Federal Trade Commission ftc.gov Summary Brand-name pharmaceutical companies can delay generic competitionMore information
IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE : AL JAZEERA AMERICA, LLC, : : Plaintiff, : : v. : C.A. No. 8823-VCG : AT&T SERVICES, INC., : : Defendant. : : MOTION TO STAY OCTOBER 14, 2013 LETTER OPINIONMore information
Federal Court Denies Motorola s Motion to Dismiss Apple s Appeal over SEPs
WRITTEN BY DANIEL P. WEICK AND KOREN W. WONG-ERVIN APRIL 28-MAY 3, 2013 PATENTS Federal Court Denies Motorola s Motion to Dismiss Apple s Appeal over SEPs On May 3, the Federal Circuit denied MotorolaMore information
Pay-For-Delay Settlements in the Wake of Actavis
Michigan Telecommunications and Technology Law Review Volume 20 Issue 2 2014 Pay-For-Delay Settlements in the Wake of Actavis Michael L. Fialkoff University of Michigan Law School Follow this and additionalMore information
VOLUME 2, NUMBER 3 Cited as 2 C.L.A.R. AUGUST 2013 IN THIS ISSUE U.S. Supreme Court Holds That Reverse Payment Patent Litigation Settlements Are Not Immune from Antitrust Review Michelle Lally, ChristopherMore information
Legal FAQ: Introduction to Patent Litigation
Legal FAQ: Introduction to Patent Litigation by charlene m. morrow and dargaye churnet 1. Who enforces a patent? The U.S. Patent and Trademark Office grants a patent. Contrary to popular belief, a patentMore information
UNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN STEVEN OLSON, Plaintiff, v. Case No. 12-C-1126 BEMIS COMPANY, INC. et al., Defendants. DECISION AND ORDER DENYING DEFENDANTS MOTION TO DISQUALIFYMore information
SENATE BILL 1ST LEGISLATURE - STATE OF NEW MEXICO - FIRST SESSION, INTRODUCED BY Joseph Cervantes 1 ENDORSED BY THE COURTS, CORRECTIONS AND JUSTICE COMMITTEE AN ACT RELATING TO CIVIL ACTIONS; CLARIFYINGMore information
Challenging EEOC Conciliation Charges
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 email@example.com Challenging EEOC Conciliation Charges Law360, NewMore information
The Whistleblower Stampede And The. New FCA Litigation Paradigm. Richard L. Shackelford. King & Spalding LLP
The Whistleblower Stampede And The New FCA Litigation Paradigm Richard L. Shackelford King & Spalding LLP Actions under the qui tam provisions of the False Claims Act ( FCA ), 31 U.S.C. 3730(b)-(h), areMore information
Proposed New Pa.R.Crim.P and Revisions to the Comment to Pa.R.Crim.P. 462 INTRODUCTION
Proposed New Pa.R.Crim.P. 1037 and Revisions to the Comment to Pa.R.Crim.P. 462 INTRODUCTION The Criminal Procedural Rules Committee is planning to recommend that the Supreme Court of Pennsylvania adoptMore information
The Benefits of Patent Settlements: New Survey Evidence on Factors Affecting Generic Drug Investment
The Benefits of Patent Settlements: New Survey Evidence on Factors Affecting Generic Drug Investment by Bret Dickey 1 Jonathan Orszag 2 July 23, 2013 3 1 Bret Dickey is an Executive Vice President withMore information
CALIFORNIA FALSE CLAIMS ACT GOVERNMENT CODE SECTION 12650-12656 12650. (a) This article shall be known and may be cited as the False Claims Act. (b) For purposes of this article: (1) "Claim" includes anyMore information
An Empirical Approach To Reverse Payment Settlements
Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 firstname.lastname@example.com An Empirical Approach To Reverse Payment SettlementsMore information
WHY A LARGE AND UNJUSTIFIED PAYMENT THRESHOLD IS NOT CONSISTENT WITH ACTAVIS Michael A. Carrier * INTRODUCTION... 109 I. THE ACTAVIS COURT S DISCUSSION OF LARGE AND UNJUSTIFIED PAYMENTS... 110 II. RULE-OF-REASONMore information
Minnesota False Claims Act
Minnesota False Claims Act (Minn. Stat. 15C.01 to.16) i 15C.01 DEFINITIONS Subdivision 1. Scope. --For purposes of this chapter, the terms in this section have the meanings given them. Subd. 2. Claim.More information
Professional. Compliance & Ethics. 29 EU Data Protection Regulation: Are we nearly there yet?
Compliance & Ethics April 2016 Professional a publication of the society of corporate compliance and ethics www.corporatecompliance.org Meet Mark Lanterman Chief Technology Officer Computer Forensic ServicesMore information
First Impressions: Shutting Down a Chapter 11 Case Due to Patent Unconfirmability of Plan. September/October 2012. Scott J.
First Impressions: Shutting Down a Chapter 11 Case Due to Patent Unconfirmability of Plan September/October 2012 Scott J. Friedman Before soliciting votes on its bankruptcy plan, a chapter 11 debtor thatMore information
Defensive Strategies in False Marking Suits After Stauffer and Pequignot
Defensive Strategies in False Marking Suits After Stauffer and Pequignot Contributed by Angie M. Hankins, Stroock & Stroock & Lavan LLP Many companies inadvertently mark their products with expired patents.More information
2015 IL App (1st) 143589-U. No. 1-14-3589 IN THE APPELLATE COURT OF ILLINOIS FIRST JUDICIAL DISTRICT
2015 IL App (1st) 143589-U SIXTH DIVISION September 11, 2015 No. 1-14-3589 NOTICE: This order was filed under Supreme Court Rule 23 and may not be cited as precedent by any party except in the limitedMore information
AN ACT IN THE COUNCIL OF THE DISTRICT OF COLUMBIA To amend the District of Columbia Procurement Practices Act of 1985 to make the District s false claims act consistent with federal law and thereby qualifyMore information
Case: 5:10-cv-01912-DAP Doc #: 21 Filed: 03/14/11 1 of 8. PageID #: 358 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION
Case: 5:10-cv-01912-DAP Doc #: 21 Filed: 03/14/11 1 of 8. PageID #: 358 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION UNIQUE PRODUCT SOLUTIONS, LTD., ) Case No. 5:10-CV-1912 )More information
IN THE UNITED STATES BANKRUPTCY COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION In re: ) Chapter 7 Liquidation ) marchfirst, INC., et al., ) CASE NO. 01 B 24742 ) (Substantively Consolidated)More information
EIGHT REASONS WHY NO-AUTHORIZED-GENERIC PROMISES CONSTITUTE PAYMENT Michael A. Carrier* I. INTRODUCTION Drug patent settlements present some of the most nuanced issues in patent and antitrust law today.More information
PROCEDURAL FAIRNESS IN COMPETITION LAW ENFORCEMENT AND THE FTC EXPERIENCE King s College, Centre of European Law London, United Kingdom October 23, 2015 Remarks of Commissioner Terrell McSweeny Good afternoon.More information
Case 2:14-cv HB Document 81 Filed 05/06/15 Page 1 of 20 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA : : : : :
Case 2:14-cv-05151-HB Document 81 Filed 05/06/15 Page 1 of 20 IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA FEDERAL TRADE COMMISSION v. ABBVIE INC., et al. : : : : : MEMORANDUMMore information
Testimony of. J. Douglas Richards Partner, Cohen Milstein Sellers & Toll, PLLC
Testimony of J. Douglas Richards Partner, Cohen Milstein Sellers & Toll, PLLC Before the Subcommittee on Intellectual Property, Competition and the Internet of the House Committee on the Judiciary RoomMore information
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA MEMORANDUM. Bartle, C.J. December 14, 2006
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA REBECCA S. ZEIGENFUSE : CIVIL ACTION on behalf of herself and all : others similarly situated : : v. : : APEX ASSET MANAGEMENT,More information
PRACTICE GUIDELINES MEMORANDUM. RE: Sample Bankruptcy Motions and Orders for Personal Injury Practitioners and Trustees
PRACTICE GUIDELINES MEMORANDUM TO: FROM: Attorneys Practicing Before Me And Other Interested Persons C. Timothy Corcoran, III United States Bankruptcy Judge DATE: January 3, 2000 1 RE: Sample BankruptcyMore information
HP0868, LD 1187, item 1, 123rd Maine State Legislature An Act To Recoup Health Care Funds through the Maine False Claims Act
PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney. Be it enacted by the People of theMore information
Supreme Court Decision Affirming Judicial Right to Review EEOC Actions
Supreme Court Decision Affirming Judicial Right to Review EEOC Actions The Supreme Court Holds That EEOC s Conciliation Efforts Are Subject to Judicial Review, Albeit Narrow SUMMARY A unanimous SupremeMore information
NEW YORK CITY FALSE CLAIMS ACT Administrative Code 7-801 through 7-810 *
NEW YORK CITY FALSE CLAIMS ACT Administrative Code 7-801 through 7-810 * 7-801. Short title. This chapter shall be known as the "New York city false claims act." 7-802. Definitions. For purposes of thisMore information
Payment System Override Deems Transaction Not Ordinary
Payment System Override Deems Transaction Not Ordinary Ames Merchandising Corp. v. Cellmark Paper Inc. (In re Ames Dept. Stores, Inc.), 2011 Bankr. LEXIS 969 (Bankr. S.D.N.Y. Mar. 28, 2011) In Ames MerchandisingMore information
IN THE UNITED STATES COURT OF APPEALS United States Court of Appeals FOR THE FIFTH CIRCUIT Fifth Circuit F I L E D November 19, 2009 No. 09-20049 Charles R. Fulbruge III Clerk DEALER COMPUTER SERVICESMore information
LEGAL UPDATE THIRD PARTY POP-UP ADVERTISEMENTS: U-HAUL INT L, INC. V. WHENU.COM. Andrew J. Sinclair
LEGAL UPDATE THIRD PARTY POP-UP ADVERTISEMENTS: U-HAUL INT L, INC. V. WHENU.COM Andrew J. Sinclair I. INTRODUCTION Pop-up advertising has been an enormous success for internet advertisers 1 and a hugeMore information
Representing Whistleblowers Nationwide
Minnesota False Claims Act Minnesota Stat. 15C.01 to 15C.16) 15C.01 DEFINITIONS Subdivision 1. Scope. --For purposes of this chapter, the terms in this section have the meanings given them. Subd. 2. Claim.More information
2:13-cv-11754-DPH-MJH Doc # 4 Filed 04/18/13 Pg 1 of 6 Pg ID 39 UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION
2:13-cv-11754-DPH-MJH Doc # 4 Filed 04/18/13 Pg 1 of 6 Pg ID 39 UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION ADDICTION & DETOXIFICATION ) INSTITUTE, LLC, ) Plaintiff,More information
8:08-cv-00541-LSC-TDT Doc # 301 Filed: 04/01/10 Page 1 of 10 - Page ID # 2724 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEBRASKA
8:08-cv-00541-LSC-TDT Doc # 301 Filed: 04/01/10 Page 1 of 10 - Page ID # 2724 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEBRASKA PETER KIEWIT SONS INC. and KIEWIT CORPORATION, ATSER, LP,More information
Settling a False Claims Act Case: Practicalities and Pitfalls
Settling a False Claims Act Case: Practicalities and Pitfalls Brian A. Hill email@example.com Jeffrey M. Hahn firstname.lastname@example.com Overview Because the vast majority of FCA cases are settled, every FCA practitionerMore information
Case 1:04-cv-01512-RBK-AMD Document 540 Filed 08/21/2007 Page 1 of 7
Case 1:04-cv-01512-RBK-AMD Document 540 Filed 08/21/2007 Page 1 of 7 COMMODITY FUTURES TRADING COMMISSION, IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY CAMDEN VICINAGE HONORABLE ROBERTMore information
Present Situation of IP Disputes in Japan
Present Situation of IP Disputes in Japan Feb 19, 2014 Chief Judge Toshiaki Iimura 1 1 IP High Court established -Apr.1.2005- l Appeal cases related to patent rights etc. from district courts nationwideMore information
ALI-ABA Topical Courses False Patent Marking: Crafting Your Defense As the Law Evolves October 27, 2010 Telephone Seminar/Audio Webcast
1 ALI-ABA Topical Courses False Patent Marking: Crafting Your Defense As the Law Evolves October 27, 2010 Telephone Seminar/Audio Webcast Select 2010 N.D. Illinois False Patent Marking Opinions and OrdersMore information
A New Headache For Employers: Whistleblower Claims Under the Affordable Care Act
March 2013 A New Headache For Employers: Whistleblower Claims Under the Affordable Care Act BY STEPHEN H. HARRIS, MELINDA A. GORDON & MARC E. BERNSTEIN INTRODUCTION On February 22, 2013, the United StatesMore information
What s Inside. Gus Chiarello, FTC Washington, D.C. Leigh Oliver, Hogan Lovells Washington, D.C.
A Publication of the Health Care and Pharmaceuticals Committee of the Antitrust Section of the American Bar Association Co-Chairs: Seth Silber Wilson Sonsini Washington, DC Christi Braun Mintz Levin Washington,More information
CLIENT MEMORANDUM FEDERAL CIRCUIT HOLDS THAT HEIGHTENED PLEADING REQUIREMENTS APPLY TO FALSE MARKING ACTIONS In a decision that will likely reduce the number of false marking cases, the Federal CircuitMore information
LITTLE TRAVERSE BAY BANDS OF ODAWA INDIANS TRIBAL COURT Chapter 7 Appellate Procedures Court Rule Adopted 4/7/2002 Appellate Procedures Page 1 of 12 Chapter 7 Appellate Procedures Table of Contents 7.000More information
A Bill Regular Session, 2015 SENATE BILL 830
Stricken language would be deleted from and underlined language would be added to present law. State of Arkansas 90th General Assembly A Bill Regular Session, 2015 SENATE BILL 830 By: Senator D. SandersMore information
CASE 0:05-cv-01578-JMR-JJG Document 59 Filed 09/18/06 Page 1 of 7 UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA 05-CV-1578(JMR/JJG)
CASE 0:05-cv-01578-JMR-JJG Document 59 Filed 09/18/06 Page 1 of 7 UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA 05-CV-1578(JMR/JJG) State of Minnesota ) ) v. ) ORDER ) Robert B. Beale, Rebecca S.More information
Going Vertical: The Hospital-Health Insurer Merger. By Christi J. Braun 1 Farrah Short
Going Vertical: The Hospital-Health Insurer Merger By Christi J. Braun 1 Farrah Short In today s health care reform environment, efficient health care delivery, stemming soaring health care costs, andMore information
Case 5:13-cv-04137-JWL-JPO Document 16 Filed 02/04/14 Page 1 of 5 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS UNITED STATES OF AMERICA, for the use and benefit of LAWRENCE KEVIN WRIGHT,More information
Case 2:07-cv-02175-JPM-dkv Document 85 Filed 01/08/2008 Page 1 of 8
Case 2:07-cv-02175-JPM-dkv Document 85 Filed 01/08/2008 Page 1 of 8 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TENNESSEE WESTERN DIVISION SPINE SOLUTIONS, INC., a Delaware Corporation,More information
INDIANA FALSE CLAIMS AND WHISTLEBLOWER PROTECTION ACT. IC 5-11-5.5 Chapter 5.5. False Claims and Whistleblower Protection
As amended by P.L.79-2007. INDIANA FALSE CLAIMS AND WHISTLEBLOWER PROTECTION ACT IC 5-11-5.5 Chapter 5.5. False Claims and Whistleblower Protection IC 5-11-5.5-1 Definitions Sec. 1. The following definitionsMore information
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA M E M O R A N D U M. STENGEL, J. November, 2005
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA THE PRUDENTIAL INSURANCE : COMPANY of AMERICA, : CIVIL ACTION Plaintiff : : v. : NO. 04-462 : PAUL M. PRUSKY, : STEVEN G. PRUSKY,More information
2015 IL App (1st) 141310-U. No. 1-14-1310 IN THE APPELLATE COURT OF ILLINOIS FIRST JUDICIAL DISTRICT
2015 IL App (1st) 141310-U FIRST DIVISION October 5, 2015 No. 1-14-1310 NOTICE: This order was filed under Supreme Court Rule 23 and may not be cited as precedent by any party except in the limited circumstancesMore information
HB 2845. Introduced by Representative Patterson AN ACT
REFERENCE TITLE: state false claims actions State of Arizona House of Representatives Fiftieth Legislature Second Regular Session HB Introduced by Representative Patterson AN ACT AMENDING TITLE, ARIZONAMore information
OSCAR ROBERTSON, et al., 70 Civ. 1526 (RLC) Plaintiffs,
NOTICE OF CLASS ACTION SETTLEMENT OFFICE OF THE CLERK UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK --------------------------------------X OSCAR ROBERTSON, et al., 70 Civ. 1526 (RLC) Plaintiffs,More information
Case 6:10-cv-01071-DNH-ATB Document 76-1 Filed 08/22/11 Page 1 of 5 UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF NEW YORK
Case 6:10-cv-01071-DNH-ATB Document 76-1 Filed 08/22/11 Page 1 of 5 UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF NEW YORK ONEIDA NATION OF NEW YORK, Plaintiff, v. Civil Action No. 6:10-CV-1071More information
Slaying the Patent Troll: Learning to Throw Lightning Bolts
Slaying the Patent Troll: Learning to Throw Lightning Bolts Presented to Association of Corporate Counsel, South/Central Texas Chapter Presented By: William B. Nash Haynes and Boone, LLC Phone: 210-978-7477More information
Case 1:03-cr-00422-LEK Document 24 Filed 05/02/06 Page 1 of 7. Petitioner, Respondent. MEMORANDUM-DECISION AND ORDER 1
Case 1:03-cr-00422-LEK Document 24 Filed 05/02/06 Page 1 of 7 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF NEW YORK PATRICK GILBERT, Petitioner, -against- UNITED STATES OF AMERICA, 1:05-CV-0325 (LEK)More information
Case 5:14-cv-00141-XR Document 37 Filed 08/13/14 Page 1 of 7
Case 5:14-cv-00141-XR Document 37 Filed 08/13/14 Page 1 of 7 IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF TEXAS SAN ANTONIO DIVISION TAMMY FABIAN, v. Plaintiffs, CAROLYN COLVIN, CommissionerMore information
IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA SETH ROBBINS, VERN COOLEY Plaintiffs, v. PHILADELPHIA SPORTS CLUB Defendant. CIVIL ACTION NO. 05-2676 ORDER AND MEMORANDUM OMore information
LR2-400. Case management pilot program for criminal cases. A. Scope; application. This is a special pilot rule governing time limits for criminal
LR2-400. Case management pilot program for criminal cases. A. Scope; application. This is a special pilot rule governing time limits for criminal proceedings in the Second Judicial District Court. ThisMore information
VII. JUDGMENT RULE 54. JUDGMENTS; COSTS (a) Definition; Form. Judgment as used in these rules includes a decree and any order from which an appeal lies. A judgment shall not contain a recital of pleadingsMore information
Workers Compensation: A Response To the Recent Attacks on the Commission s Authority to Suspend A Claimant s Benefits
Workers Compensation: A Response To the Recent Attacks on the Commission s Authority to Suspend A Claimant s Benefits by Charles F. Midkiff Midkiff, Muncie & Ross, P.C. 300 Arboretum Place, Suite 420 Richmond,More information
MINNESOTA FALSE CLAIMS ACT. Subdivision 1. Scope. --For purposes of this chapter, the terms in this section have the meanings given them.
As amended by Chapter 16 of the 2013 Minnesota Session Laws. 15C.01 DEFINITIONS MINNESOTA FALSE CLAIMS ACT Subdivision 1. Scope. --For purposes of this chapter, the terms in this section have the meaningsMore information
2015 TAX COURT JUDICIAL CONFERENCE CONFLICTS AND CHAOS: THE IMPORTANCE OF TIMELY RECOGNIZING AND MANAGING CONFLICTS OF INTEREST AND RELATED PROBLEMS IN TAX LITIGATION Discussion Hypotheticals May 22, 2015More information
DEPARTMENT STORES NATIONAL BANK CREDIT CARD DISCLOSURES. This APR will vary with the market based on the Prime Rate.
(DSNB180TC122315) (PL068) DEPARTMENT STORES NATIONAL BANK CREDIT CARD DISCLOSURES Interest Rates and Interest Charges Annual Percentage Rate 24.75% * (APR) for Purchases Store Accounts This APR will varyMore information
STATES DISTRICT COURT EASTERN DISTRICT OFMICHIGAN SOUTHERN DIVISION. Plaintiff, v. Case No. Hon. Magistrate Judge UNITED STATES DEPARTMENT OF JUSTICE,
2:13-cv-12939-PJD-MJH Doc # 1 Filed 07/06/13 Pg 1 of 11 Pg ID 1 DETROIT FREE PRESS, a Michigan corporation, STATES DISTRICT COURT EASTERN DISTRICT OFMICHIGAN SOUTHERN DIVISION Plaintiff, v. Case No. Hon.More information
Case 08-01176-AJC Document 1 Filed 03/01/2008 Page 1 of 12 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF FLORIDA MIAMI DIVISION
Case 08-01176-AJC Document 1 Filed 03/01/2008 Page 1 of 12 UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF FLORIDA MIAMI DIVISION In re: JOSE SANCHEZ Case No.: 01-42230-BKC-AJC and FANNY SANCHEZ, ChapterMore information
Title 5: ADMINISTRATIVE PROCEDURES AND SERVICES
Title 5: ADMINISTRATIVE PROCEDURES AND SERVICES Chapter 337-A: PROTECTION FROM HARASSMENT Table of Contents Part 12. HUMAN RIGHTS... Section 4651. DEFINITIONS... 3 Section 4652. FILING OF COMPLAINT; JURISDICTION...More information
Acting Together: State Attorneys General and the Rise of Multi-State Litigation. Thurbert Baker. Andrea Geddes. McKenna Long & Aldridge LLP
Acting Together: State Attorneys General and the Rise of Multi-State Litigation Thurbert Baker Andrea Geddes McKenna Long & Aldridge LLP 303 Peachtree Street, NE, Suite 5300 Atlanta, GA 30308-3265 (402)More information
NEW YORK FALSE CLAIMS ACT STATE FINANCE LAW, ART. XIII (2013) 187. SHORT TITLE This article shall be known and may be cited as the "New York false claims act". 188. DEFINITIONS As used in this article,More information
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO. v. No. 09-CV-956 JEC/DJS MEMORANDUM OPINION AND ORDER
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, Plaintiff, v. No. 09-CV-956 JEC/DJS TRICORE REFERENCE LABORATORIES, Defendant. MEMORANDUM OPINIONMore information
Case 4:02-cv-00066-HL Document 136 Filed 02/10/09 Page 1 of 11 IN THE UNITED STATES DISTRICT COURT FOR THE MIDDLE DISTRICT OF GEORGIA COLUMBUS DIVISION UNITED STATES OF AMERICA : ex rel. GLENN F. NICHOLSMore information
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH ORBIT IRRIGATION PRODUCTS, INC., a Utah Corporation, v. Plaintiff, SUNHILLS INTERNATIONAL, LLC, a California limited liability company; andMore information
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT. No. 10-3272. In re: JOHN W. HOWARD, Debtor. ROBERT O. LAMPL, Appellant
UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT No. 10-3272 In re: JOHN W. HOWARD, Debtor NOT PRECEDENTIAL ROBERT O. LAMPL, Appellant VANASKIE, Circuit Judge. On Appeal from the United States DistrictMore information
FEE SHIFTING IN PATENT LITIGATION Sughrue Mion, PLLC Abraham J. Rosner May 2014 I. BACKGROUND In the U.S., each party to litigation ordinarily pays its own attorney fees regardless of the outcome (calledMore information
UNITED STATES DISTRICT COURT DISTRICT OF MINNESOTA Roger Krueger, et al., Plaintiffs, v. Ameriprise Financial, Inc., et al., Defendants. Case No. 11-cv-2781 Judge Susan Richard Nelson NOTICE OF CLASS ACTIONMore information
. MINNESOTA FALSE CLAIMS ACT Sec. 24. [15C.01] DEFINITIONS. Subdivision 1. Scope. For purposes of this chapter, the terms in this section have the meanings given them. Subd. 2. Claim. "Claim" includesMore information
33 U.S.C. 3729-33 FALSE CLAIMS ACT STATUTORY LANGUAGE 31 U.S.C. 3729. False claims (a) LIABILITY FOR CERTAIN ACTS. (1) IN GENERAL. Subject to paragraph (2), any person who (A) knowingly presents, or causesMore information
Case 8:10-cv-02549-EAJ Document 20 Filed 11/01/11 Page 1 of 9 PageID 297 UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION
Case 8:10-cv-02549-EAJ Document 20 Filed 11/01/11 Page 1 of 9 PageID 297 TORREY CRAIG, Plaintiff, UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION vs. Case No.: 8:10-CV-2549-T-EAJMore information
SMALL CLAIMS COURT IN ARKANSAS Note: The information contained in this publication is designed as a useful guide to remind you of your rights as a citizen of this state. You should not rely totally onMore information
Case 2:11-cv-02555-RDR-KGS Document 90 Filed 04/16/12 Page 1 of 7 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS.
Case 2:11-cv-02555-RDR-KGS Document 90 Filed 04/16/12 Page 1 of 7 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS PAULA M. MARS Executor of the estate of Mindy Knopf, Plaintiff, v. CaseMore information
United States Court of Appeals
In the United States Court of Appeals For the Seventh Circuit No. 14-2423 IN RE: SWEPORTS, LTD., Debtor-Appellee. APPEAL OF: MUCH SHELIST, P.C., et al., Creditors-Appellants. Appeal from the United StatesMore information
IN THE UNITED STATES DISTRICT COURT EASTERN DISTRICT OF ARKANSAS WESTERN DIVISION JOYCE FULLINGTON PLAINTIFF v. No. 4:10CV00236 JLH PLIVA, INC., formerly known as Pliva USA, Inc.; and MUTUAL PHARMACEUTICALMore information
It s official: Good-faith exception part of state law By PAUL THARP, Staff Writer
It s official: Good-faith exception part of state law By PAUL THARP, Staff Writer firstname.lastname@example.com As Rep. Paul Stam sees it an injustice to the people of North Carolina has been rightedMore information
Case 2:10-cv-00802-CW Document 90 Filed 02/02/15 Page 1 of 5 IN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH, CENTRAL DIVISION
Case 2:10-cv-00802-CW Document 90 Filed 02/02/15 Page 1 of 5 IN THE UNITED STATES DISTRICT COURT DISTRICT OF UTAH, CENTRAL DIVISION MURIELLE MOLIERE, Plaintiff, v. OPTION ONE MORTGAGE, et al., Defendants.More information
Court of Appeals. First District of Texas
Opinion issued April 19, 2016 In The Court of Appeals For The First District of Texas NO. 01-15-00361-CV FREDDIE L. WALKER, Appellant V. RISSIE OWENS, PRESIDING OFFICER OF THE TEXAS BOARD OF PARDONS ANDMore information
The trademark lawyer as brand manager
The trademark lawyer as brand manager This text first appeared in the IAM magazine supplement Brands in the Boardroom 2005 May 2005 For further information please visit www.iam-magazine.com Feature TheMore information
PERSONAL INJURY COMPENSATION CLAIM GUIDE PERSONAL INJURY COMPENSATION CLAIM GUIDE This booklet has been produced by D.J. Synnott Solicitors to give our clients an understanding of the personal injury compensationMore information
No. 1-12-0762 IN THE APPELLATE COURT OF ILLINOIS FIRST JUDICIAL DISTRICT
2014 IL App (1st) 120762-U No. 1-12-0762 FIFTH DIVISION February 28, 2014 NOTICE: This order was filed under Supreme Court Rule 23 and may not be cited as precedent by any party except in the limited circumstancesMore information
Reverse Payment Patent Settlements in Europe. John Schmidt, Shepherd and Wedderburn LLP
Reverse Payment Patent Settlements in Europe John Schmidt, Shepherd and Wedderburn LLP ABA Business Law Section Antitrust Committee Programme San Francisco APRIL 17 2015 What s the issue? Consider theMore information


text:
With the eclipse in sight, Pope Francis warns against turning to astrologers and fortune tellers
People are asking for deeper, occult meaning of the upcoming eclipse. The August 21 solar eclipse will be visible mostly in the United States, but it's impact is already being noticed around the world. It's fueling an interest in astrology and fortune telling, as such events often do. Now, Pope Francis has issued a warning
…Read more

subset: commoncrawl


text:
Hi all,
Sorry for the lack of activity. I haven't had the time to keep things current. However, I'd love to keep it rolling and expanding and if you'd like to help, I'd be thrilled to have you. Please contact me if you'd like to be a regular or occasional writer, tweeter or if you have great WordPress skills and some effort to lend.
In the meantime, the BoP Designer Daily (paper.li news digest) is automatically refreshed every day to keep you up to date on what's going on in the world of social innovation and design. Feel free to retweet stories and share with others. Also be sure to check out friends and colleagues on the list of other great blogs and websites.


text:
Taking Matters into Our Own Hands
Daily Bible Reading – John 15-18
Today's Key Passage – John 18:1-14
Imagine for a second that you are Peter. You have spent quite a while following Jesus. You are friends, and you love Him dearly. All of a sudden, men have come to arrest your friend and take him off to an almost certain death. What do you do? Do you simply stand by and allow this to happen, or do you try to take matters into your own hands and stop this atrocity? Peter did the only thing he could think of to try to stop Jesus from being arrested and killed – he drew his sword and cut off the ear of Malchus. Peter was ready to do battle right there in the garden to save Jesus' life. While this may sound courageous or even heroic, there is a problem. His actions were not in line with God's will. God's will was for Jesus to be arrested, crucified, and resurrected to save the entire world. Jesus knew the plan, and immediately stopped Peter. In addition, we see in Luke's account that Jesus also healed Malchus' ear, thus undoing the damage Peter had done by stepping in.
There are many times when we feel tempted to try to step in and help God. It can be tempting to take matters into our own hands and try to force the issue, especially if we perceive that God is not taking any action on His own. Of course, just like in Peter's case, most of the time trying to step in for God leads to sin. We must trust God to work out His plan in His own way. As I have said in the past, God does not need our help. He knows what He is doing, even when we are unable to figure it all out. When we try to step in and force the issue, we only make things worse, and often we simply create more work for God to have to clean up. Trust that He knows what He is doing. Trust that His plan is working in your life. Instead of trying to lead, when it comes to God's will our best course of action is to follow Him.
During your Bible reading today, what "key passages" stood out to you? Leave a comment below to share what God is showing you about His Word today.
To become a fan of The Daily Bible Plan's Facebook Page, CLICK HERE.
To follow me on Twitter for inspirational tweets, click the follow button – Follow @kevin_griggs
If you like this post, please SHARE it with others to spread the Word of God.
May the grace of the Lord Jesus Christ be with you today.
Posted on December 23, 2014, in 04 - John and tagged Bible, Christian, Conflict, Daily Bible, Daily Devotional, Faith, God, God's Character, Godly Living, Jesus, Questioning God, Religion, Sin, Trust, Waiting. Bookmark the permalink. Leave a comment.


text:
Set Visit: The Eye
was a Saturday afternoon in downtown
As I found my destination, the sun peaked out behind a few scattered clouds. It is there that I walked into The Standard Hotel. But there was nothing standard about it. It has an art deco feel almost like an Argento nightmare with shades of David Lynch and a soundtrack filled with Coldplay. This was where it was going to happen; I was about to get a few words with the lovely Jessica Alba, along with a few other journalists. I strolled through a long hallway and pushed the call button for the elevator. When it arrived, it took me to a familiar site. On the roof was a beautiful pool with a few waterbed gazebos and these long and comfortable couches with tables set up alongside. Looking around, one of the other dudes made the realization that we were standing in the same place where they shot the final sequence in CRANK. Well you can imagine how that made us all feel, the excitement of standing exactly where Jason S kicked some bad guy ass.
Soon after that realization, the reason why we were there arrived. First, we spoke to Jessicas leading man, Alessandro Nivola who wasnt even supposed to be here today, yet he came to chat it up and he seemed like a pretty cool guy. His view of the film and his directors was very hopeful and he was positive that this was going to be one of the better remakes. Wait and see folks, after all, it could be better than a GRUDGE 3. Then again we shall see. But he was a really positive dude and I appreciated the time he took to speak to us. And he dug the waterbed gazebos.
After that, directing team David Moreau and Xavier Palud joined the lovely Jessica Alba for a little chat. It was there we talked about Jessicas wonderful skills as a violinist and the good cop/bad cop strategy of two directors for the price of one. And one thing that struck me about Ms. Alba is that the many times the films actor wranglers (its what I like to call them) would come and tell her they needed her back on set, she would calmly say, a couple more questions, and gave us as much time as she possibly could. Not only is she beautiful, she is sweet, willing to share her food and gave as much time to talk as she possibly could. What a classy dame.
After the chatter, we were all lead onto a street just outside the hotel where they were filming a scene with Jessica getting out of a cab. Yes, you may think that to be not very exciting, but hold your breath. Are you ready? They had a rain machine. Yes, I am serious. You see, it makes it look like it's raining. They are not shitting you at the Universal Studios tour when they say they can make rain. Not only did they have rain but they had picture cars (which, if you took the above mentioned tour, you would know what that is) and they had extras (not Ricky Gervais though). We were watching alongside some passerbys who were getting a glimpse of movie magic. And sadly, when the rain started to pour, I was so excited to get rained on by Hollywood rain, but the PA didnt want us to be in that area because that would mean she would have to get wet too. See, she had to keep the wolves at bay tough job.
But in the end, I got to hang on the groovy rooftop that CRANK made famous and I got to talk to Jessica Alba. I also got to meet the directors behind THEM (ILS in French), which has a whole lotta great word of mouth. Im looking forward to checking it out and The Arrow had some great things to say about it. Now the question is, can they make this fresh and not a stale and unnecessary remake? Alexandre Aja made THE HILLS HAVE EYES work in my opinion, so it is possible. And frankly, Im sure many of you would have no problems watching Jessica Alba get out of a taxi cab.
Alessandro was saying how the style of you guys shooting is very conducive to working with both of you together. How do you guys work together, and how is it working with Jessica and Alessandro together?
David Moreau: Working with Jessica was a nightmare, but hopefully shes not here. [Laughter] Working with Xavier is great. We basically do everything together. Its not about its about pre-production everything together. And when we are on the set, maybe there is one who speaks more than the other. It is pretty similar to working with one director.
Jessica Alba: Theyre excellent. They really compliment each other. Theyre like a great married couple - the ideal marriage. They really are each others ying and yang.
Does that make it feel like good cop/bad cop, or like mom and dad?
DM: I think good cop/bad cop, but I wont say who is [the] good cop. Or mom and dad, no, I would say more good cop/bad cop oh, everything I think.
JA: [to David] But you guys have the same vision, right?
DM: No. [Laughter]
JA: No?
DM: We are just about a ping-pong, you know. When you are alone facing your own doubts, there is just you and the left and right part of your brain. When you are two [people], you are exposed more and say, Oh, we should do that, and then the other one is like, Oh, I dont know. Its just about emulating.
Xavier Palud: [You need] to be concentrating on the story.
DV: Maybe it is good for another movie, but not for this one. We follow the same light.
Jessica, what was your chose for going to the thriller. [Its] something we havent really seen you get involved in.
JA: I wanted to do it for a long time. I wanted to do something that transcended the genre. Fantastic Four is a big Hollywood comic book movie but what attracted me to it is that the female superhero was more a maternal character in a family dynamic and that to me was more interesting than just a girl in leather whos sexy cutting people heads off. So purposefully went to doing a comic book movie that to me sort of goes into being a family movie as well. And in this I think its really intelligent and its a beautiful story of this girls journey about gaining her sight and dealing with it. Never having it, gaining it, and losing her sanity. And it just happens to be wrapped up in a horror movie. I just think that is so much more interesting than just running around in a white t-shirt or something.
DM: [Jessica in a white t-shirt] sounds kind of interesting. [Laughter]
JA: I totally appreciate that stuff, I do, but its a lot more interesting for me to play someone who is blind and a classical violin player than, you know.
DM: Than running around the streets with a t-shirt.
JA: Yeah, with a t-shirt.
What was it like learning the violin?
JA: Its impossible!
DM: Dont say that!
JA: Its bullshit! Its absolutely impossible. And [the director] picks really difficult music so the music I am learning is the music people play in university after theyve been playing since they were five. So they play their entire life, go to university, and then they play Mozart. No! Thats what Im doing now. Three months learning how to even hold the instrument. I havent memorized all the
DM: All the notes are accurate.
JA: All the notes are accurate. I am playing the actual notes of the music. It just sounds like a cat in heat. Whaa Rrraaa Rhe [Laughter]
How many hours a day you rehearsing for that?
JA: Average, an hour and a half when I can. Three hours yesterday. Fifteen minutes during my lunch because Ive been working 16 hour days and I really only have 15 minutes to study this wonderful piece that he chose to be in the movie. Its very difficult. It takes a lot of dedication and hard work but thats why were in this crazy ass business because we get to do silly things and pick up an instrument that I would never in a million years pick up. I have a great appreciation for it and I want to represent musicians and people who are blind in the best way I can. I dont take it lightly. Its a nice challenge to have I have to say.
Can you describe what we are going to see today?
DM: We are shooting the beginning of the movie where we see [her character] for the first time and shes getting out of the cab under the rain.
JA: Can you please tell them, no we wont tell them how difficult it was.
DM: She is blind.
JA: I have my violin strapped to me, my purse, a cane and an umbrella and its torrential downpour. And Im like, how the hell am I suppose to get out of the taxi? So I have someone pushing out, that you cant see. Yeah, it was not a cute thing. For a few hours I was soaked, but its going to look great.
How challenging was it to play someone who was blind?
JA: It was very [challenging]. It was weird, [the idea] of losing your sight is very daunting so I would walk around my house and I walked with a cane and sleep shades on in complete darkness. You get really claustrophobic. Even just drinking water and anything, it just feels very claustrophobic. There have been a few little panic attacks and nightmares about being blind. Its a really different reality. Its a really very different reality to live. Now I look for Braille everywhere. There are no menus in Braille.
So if someone is not sighted and they go to restaurant, they just have to trust whoever is reading the menu to them. There are just things that I never would even think about. You know on soda at McDonalds they have a little bit of Braille on the lid, that I really wasnt aware of. Its definitely interesting. But people who are blind can function in the world just like everyone else. I always thought it was always such a handicap that you couldnt really do what everyone else does, and they do everything. This woman that we met in New Mexico, who they found, shes 25 years old. Shes a classical musician, shes a singer and shes a vocalist. She lived in London for two years. She lives in Boston now. She travels by herself all the time. She doesnt need anybody to get around. And, she competes with people who are sighted for concerts. Shes really inspiring, and shes kind of my inspiration for the movie, for sure.
Can you kind of talk about what The Eye is, and how you got involved [in the movie], and working with Jessica?
a thriller about a girl who has been blind most of her life, gets a
cornea transplant, and has real trouble making the adjustment into
the seeing world and starts hallucinating.
I play a neuro psychologist that she goes to see to ease her
transition. He is initially
fascinated by her disorder and then starts to fall for her a bit,
and he ends up jeopardizing his career to try to help her track down
who the donor was. He
drives her down to
movie] was just something that came along.
I had just finished a movie at the end of last year in
Because if you are able to disassociate too easily with the world of the film it becomes hard to imagine yourself in those type of circumstances. The more real the world is, I think the more scary it is. And they had a real knack for that. And also, their film was about a couple, a man and a wife, who get terrorized by young people in Bucharest. There was something really believable between the couple. In the first 20 minutes they had established a rapport between them that was believable and so then everything that unfolded from there was formed by their real relationship. That was important in this [movie] because my character is not involved so much in the horror element of the story, so it was really important that my scenes with Jessica play out in a specific and believable way. It seemed like they were the boys for the job, and that was that. And, two months in Albuquerque, which Im glad are over.
How is it working with two directors at once? Had you done that before?
I never have. Its all the rage. [Laughter] Im sure Im never going to with [just] one director ever again. I didnt know how that was going to work. I kept asking them but they couldnt seem to explain it but once we started working it was obvious how it worked with these two anyway. David is a very extroverted, sort of charismatic persuasive guy who despite his broken English has an easy time talking to the actors, and to corral everybody on the set. Hes very dynamic that way. Xavier is much shyer and quieter and more visual. There was a sort of ying and yang to their dynamic together. They didnt seem to argue much. The only time I heard them argue was when we had been filming nights all week and Xavier was afraid to have David drive him home because he had nearly crashed the car the night before. So other than that it seemed to go very smoothly.
Is there a different style each of them shoot in, rather than like one will shoot the real hard stuff?
No. They both seem to be on the set the whole time. They would kind of whisper to each other between takes and confer about their thoughts. I spent a lot of time with them because there isnt a lot to do in Albuquerque, so wed hang around their house most days with our laptops open on the piano trying to find the lyrics to all these songs that we butchered. I got the sense that theyd spent a lot of time together. They had grown up together for quite a few years. They had very similar taste in movies. When we watched things together they both tended to point out the same kinds of visual things that they liked. Obviously, they have an easy language and rapport together. I dont know why [having two directors on one movie] is happening so much. I guess its such a hard job that once you realize you can do it with somebody else that you might as well go ahead; although apparently theyre sharing the fee.
Over the last few years weve had The Ring and The Grudge and all these other movies that have come here and done very well. Do you think this is the next step in that continuation or is it completely different?
The challenge anytime youre making a movie and trying to test the genre is to bring something that feels different to that. I think, from what I can tell [is that] theyve set out to make a movie that has some kind of feeling of reality. Increasingly, the horror movies that Ive seen just dispense with any kind of attempt to create a reality in the world of film, and its just one kind of ghoulish moment after another. I think this was a perfect movie for Jessica to do also because she has ambitions to be taken really seriously as an actress and she hasnt had the opportunity until now to do a role that enabled her to play a real character, and to behave in ways that didnt involve action and comic book heroes and all that kind of thing.
What is it about Jessica and this movie that is going to [help her career]?
I think the nice thing for her is that she is very unadorned. Shes not caked in makeup. She has a very real look and shes a very beautiful girl that comes across very natural. There is a feel about the movie that is very understated. I think that shes able to talk and behave like a real person and she does it in a really classy way, a very quiet and understated way so I feel like its going to be important for her in that way. And theyve populated the film with really good actors.
Do you have any Laurel Canyon style love scenes in the film?
Sadly not. Im doing a movie with Jessica Alba and theres no naked scene in the pool.
EYE" is slated for release on
October 12th, 2007


text:
Status: Open
Know more about this business than we do? Cool! Please submit any corrections or missing details you may have.Help us make it right
Leslie's Swimming Pool Supplies, the world leader in residential and commercial pool supplies. The best selection of pool cleaners, pool chemicals and pool equipment for your above-ground pool, in-ground pool or spa. Nation's leader in swimming pool service. Installation and Repair.
Be the first NJ.com user to add photos or videos of Leslie's Swimming Pool Supplies
I have been purchasing my pool supplies from here for years. Until yesterday that is . I phoned the store to inquire about an item and the first person I spoke with was disinterested and...
Leslie's Swimming Pool Supply is located at 846 State Route 35, Middletown, NJ. This business specializes in Sporting Goods.
World's pool supply leader. National commercial division. Pool cleaners, chemicals, equipment & more.


text:
Beaba Multiportions - Pink
Beaba Multiportions - Pink
- BPA-free silicone
- designed with 2-oz. cups for freezing seven favorite sweet or savory foods
- airtight plastic lid preserves their fresh flavors, textures and nutrients
- At dinnertime, the individual frozen portions slip out, ready for reheating in the Beaba Babycook or a microwave oven
Amazon Product Description
Beaba Multiportions

Beaba Multiportions are designed for freezing and storing food for babies. Each features seven individual portions. Made of silicone, these containers are lightweight and easy to manage. They are conveniently freezer-, microwave- and dishwasher-safe.

Why You'll Love It:  Beaba Multiportions helps you to prepare and store fresh and healthy food for baby.

Features

Makes preparing and storing food easy

Freezer-, microwave- and dishwasher- safe

Made of silicone

 Durable and lightweight

BPA-free

Product Details
- Brand: BEABA
- Size:
- Manufacturer: PEEK-A-BOO USA
- Model #:
- TGBB Code: BEABA-Silicone-Multi-Portion-Freezer-Tray-Pink
- Click for More Details


text:
Garden Dragonfly Mobile
- Product Details
- Delivery & Returns
- Reviews (0)
- Write Review
Garden Dragonfly Mobile
This beautiful mobile is a great addition to any garden, conservatory or patio. Select from 3 different light modes, flashing, alternate flashing and constant. Each dragonfly glows a different colour and will be great to use on an evening.)
Product Features
- Requires 3 x AAA Batteries (not included)
- Size 11 x 11 x 34cm (4 ¼ x 4 ¼ x 13 ½
Standard Delivery to the UK £4.99
We deliver to all UK postcodes, including Northern Ireland, Isle of Man, Scilly Isles and Channel Islands.
Currently we are unable to deliver to Eire
Orders are despatched by our courier 'Hermes' usually within 72 hours and normally delivered to your door within 7-14 days
Click here for our full delivery terms


text:
Students who are contemplating about taking an online business management degree program have myriad of choices as well as on their area of specialization. But it will take a bit of perusing and research to sort the options by the type of online school, requirement for the degree and the cost that will be suitable for you. We have compiled the necessary information to assist the student and narrow down their choices.
A Short but Comprehensive Guide about Online Business Management Degree Programs
Managers on different sectors are highly responsible for the success of the business. They are required to finish a post-graduate course in order to effectively assume the role of being a leader. Let us take a more comprehensive look on the timeline of Online Business Management Degree Programs.
Associate Degree
The associate degree in management may last for 2 years, and it is also referred to as associate degree in Business Management. It highly varies on the curriculum and institution. Antonelli College's online business management degree program a 19-month program that will provide the student about the basic of general education and business knowledge. Contingent upon the program, the Associate degree may include 1/3 about management, 1/3 on general business and the remaining 1/3 about general education. Core programs usually include communication, human resources, marketing, entrepreneurship, and accounting.
Bachelor's Degree
The Bachelors level in Online Business Management Degree requires a 120-hour program that usually last for 4 years. Theoretically, it is consists of 2-year basic education in the fields of science and liberal arts and at least 2 years of concentration in the management area. Typically students are expected to maintain a minimum grade of 2.0 GPA. The course is basically a semblance of 4-year bachelor in business curriculum, but the major elective subjects heavily focus on human resources and project management, supply chain, business law, financial management, leadership and organizational structure.
Master's Degree
Major universities and colleges are offering this Online Business Management Degree. The program may take from 1-3 years contingent upon the length of the program and the extent of time that they have to work. Students of business management have 2 Master degree options to choose from; MBA (Master of Business Administration) and a Master of Business with specialization (i.e. Accounting or Marketing). There are more than 2,000 educational facilities offering MBA, and most of them are focusing entirely on leadership skill and practical management. The 30% of the entire curriculum is actually similar with other Master degree. Masters with specialization is more concentrated on theoretical and academic which is centered on research, analysis and a thesis.
Finally, when choosing the school that offers Online Business Management Degree, you should think about quality. They should be accredited, support the alumni and student and an efficient delivery of their online course system.


text:
DEALS AND DISCOUNTS--This Saturday, Sue Helmy and I resolved to journey to the Los Angeles Memorial Coliseum on a mission to discover what the fuss about Senator Bernie Sanders is all about. Joining us were a couple of activist friends of mine and Sue's daughter's best friend from college. We were especially excited to be attending with Beshoy – the college friend – because he looks like Jesus. Since Bernie looks like Santa Claus, we figured we couldn't really do any better than hanging out with Jesus AND Santa Claus all at once. After all salvation from fire and brimstone and free gifts in December are both PRETTY GOOD DEALS.
We opted to bus it on over to that iconic structure near USC. LA Metro bus fare has gone up since I last rode – now at $1.75 a trip, with transfers at 50 cents a pop. We had a great time riding with our fellow Angelinos down to the venue even though there was some confusion since we hadn't taken much time to read the directions on the Metro.net trip planner. HINT: PAY ATTENTION IF YOU DO THIS AT HOME!
After about 45 minutes, we reached our destination in good spirits and proceeded to line up serpentine-style. It took us about two hours to get through. Meanwhile, we got buttons for two bucks each and some Bernie rolling papers for three. We made it through the perilous purview of the surly TSA and Secret Service types and into the plaza of the coliseum. There, we sat around on the grass and ate from food trucks and danced to the tunes of Ozomatli. Then we heard from Susan Sarandon and Dick Van Dyke before Bernie came out and introduced us to his family.
The first thing Bernie did was pay tribute to the late great Muhammad Ali. He talked about Ali's courage in risking it all to stand up to racism and warmongering. He then went on to outline his platform which, to my mind, sounds like the DEAL OF THE CENTURY! What we're talkin' here is what could be…
What they like to call the "Great Depression" was the last time we had an economic crisis approximating the one we all just saw brought on around 2008 by the big boys on Wall Street. Times got so rough then, that the government, under FDR's administration, was forced to pass out a damn good deal to the American public. Here are…
Creation of agencies such as the Public Works Administration, the Civil Works Administration and others (the CWA alone put to work 4 million people in two months
Rebuild America Act,, investing $1 trillion over five years to modernize our infrastructure. Creating more than thirteen million good-paying jobs
Passing of the Social Security Act. The initial version, the Economic Security Act, included national health care
Lifting the cap of $250,000 for Social Security and a free national health care system
Creation of the Federal Housing Administration and Home Owners Loan Corporation to regulate mortgages and housing conditions and preventing foreclosure
Expanding affordable housing, promoting home ownership, re-invigorating HARP to help prevent foreclosure, fighting homelessness and racial inequalities in housing quality
The National Labor Relations Act of 1935 (Wagner Act) guaranteed the right of employees to collective bargaining
Fighting for the Employee Free Choice Act. This would allow a union to be certified as the official union to bargain with an employer if that union gets the signatures of a majority of workers. It would have done away with the present right of an employer to come back AFTER THAT and demand another separate ballot.. Third, the bill would increase penalties on employers who discriminate against workers for union involvement.
Enactment of Glass-Steagall, preventing commercial banking to be separate from investment banking, thereby
Enactment of a new version of Glass-Steagall. Sanders thinks too-big-to-fail banks are bigger and riskier than ever before. They are even bigger than 2008 with too much power and a threat to our democracy.
The rapid climate change that is affecting our planet today is increasingly presenting the threat of not only natural disasters, but also food scarcity and quality, water quality, air-borne pathogens and a host of ills which threaten the future of humanity. This thread did not exist to this degree in 1933.
On the one difference I've mentioned here – and it is not the only one, Sanders is unequivocal. I took this quote from his website where he outlines an entire plan on the matter, complete with video y todo:
The debate is over. The vast majority of the scientific community has spoken. Climate change is real, it is caused by human activity, and it is already causing devastating harm here in the United States, and to people all around the globe. So what are we going to do about it? We will act boldly to move our energy system away from fossil fuels, toward energy efficiency and sustainable energy sources like wind, solar and geothermal because we have a moral responsibility to leave our kids a planet that is healthy and habitable. - Senator Bernie Sanders
Sanders spoke at the rally about the original people of this land and about how much we can learn from their traditional values of respecting the environment and preserving it for future generations. He spoke about his real concern that there will be enough safe drinking water for all people in the coming period.
All in all, we came away with a feeling of inspiration that whatever happens, there is a big movement underway to hammer out some real solutions to some long-held problems. We all agreed that would be the best deal ever.
Check out all these programs at www.berniesanders.com
(Jennifer Caldwell is a an actress and an active member of SAG-AFTRA, serving on several committees. She is a published author of short stories and news articles and is a featured contributor to CityWatch. Her column at www.RecessionCafe.wordpress.com is dishing up good deals, recipes and food for thought. Jennifer can be reached at email@example.com. Facebook: http://www.facebook.com/jennifercald - Twitter: @checkingthegate)


text: The Association of Pennsylvania State College and University Faculties (APSCUF) announced a state-wide strike on October 19 as a result of failed wage contract negotiations with Pennsylvania's State System of Higher Education. This video shows students at Millersville University, in Millersville, Pennsylvania, joining sides with the faculty to sing a rousing rendition of "Hello From the Picket Line", a parody of Adele's song "Hello." Protests took place in state-funded universities across Pennsylvania on October 19, with the majority of student participants joining sides with the faculty. Credit: Instagram/okaycassiej


text:
Disney (NYSE:DIS) has big synergy advantages over Microsoft (NASDAQ:MSFT), Salesforce.com (NYSE:CRM), Google (GOOG/GOOGL), Verizon (NYSE:VZ) and AT&T (NYSE:T) as they prepare bids for Twitter (NYSE:TWTR).
Investment bankers know that Twitter, as a tweet machine, is a stagnant business. But social media and telecommunications investors recognize Twitter's potential value as a platform to distribute video directly, as "cord-cutting" spreads from millennials to older demographic groups.
Television cord-cutting has continued over the last four years with, just 76 percent of households paying for cable television connections at the end of 2015, according to a Pew Research survey. About 15 percent of households have cut the cord and 9 percent are so-called "cord-nevers," who have never signed up for cable TV.
That was not a problem for cable companies like Comcast (CMCSA) and Time Warner Cable (TWC), because they made up for lost TV revenue by charging more for broadband Internet connections, imposing usage caps and offering online package deals.
But a Pew revealed that only 67 percent of homes are paying for broadband Internet connections this year, down from 70 percent in 2013. The results mark the first time in decades that the reach of wired Internet shrank among households. The main driver for the contraction is that 13 percent of households now report they are "smartphone only," up from 8 percent two years earlier. The motivation for eliminating broadband connections is similar to the rational for getting rid of cable television, i.e. money.
According to SunTrust's top-ranked Internet analyst Bob Peck, a Twitter deal could happen for around $27 per share, or about 20 percent higher than the current $22 a share. He basis his estimate on the 30-, 60- and 90-day stock price moving averages after a 40 percent take-out premium. That generates a $27, $26, and $24 stock price, very close to Twitter's original $26 initial public offering price. But that also values the company at $25 billion, a very high comparative market valuation of about 6.1 times revenue and 22 times the earning before interest, taxes, depreciation, and amortization of debt.
Aged 18-36-year-old subscribers to Netflix are nearing cable's subscription numbers for those. Statista analytics predicts that this cord-cutting trend is beginning to be embraced by older demographics, creating an existential threat to cable's business model.
In response, analysts at J.P. Morgan recently boosted their price targets by $1 trillion on the four so-called "FANG" stocks: Facebook (NASDAQ:FB) to $175, from $170; Amazon (NASDAQ:AMZN) to $1,000, from $925; Netflix (NASDAQ:NFLX) to $125, from $116; and Alphabet (Google) to $1,025, from $950.
Twitter stock trended upward on the news. But Disney's stock traded down because their ESPN and ABC media units lack an in-house social media platform to continue to amplify their audience reach.
Twitter's live streaming efforts with companies like the NFL and its own Periscope platform are the only innovative features that are sparking buy-out interest from Disney and others.
Disney has significant advantages over other bidders to acquire Twitter. First, Twitter's CEO Jack Dorsey serves on Disney's Board of Directors. But the biggest advantage is that Disney owns a 33 percent stake in BAMTech, the tech spinout from Major League Baseball that owns the app powering Twitter's streaming of NFL games on the web.
That means there would be virtually no "hard tech" integration problems for Disney to leverage combining its content with the live streams and commentary being experimentally demonstrated by Twitter for ESPN's broadcast of Thursday Night Football.


text:
From Our Editors
Fitcorp's trainers have big shoes to fill. Founder Gary Klencheski earned his exercise technician certification from the American College of Sports Medicine and served on the Governor's Committee on Physical Fitness and Sports for 20 years. Klencheski's passion and expertise trickle down through each of his gyms' eight facilities, where each personal trainer has a degree in exercise science, a nationally accredited certification, and the charisma of a dictator holding pompoms.
The gym's array of fitness services includes cardio and strength-training equipment, as well as group Pilates, yoga, boot-camp, and Zumba classes. Massage and acupuncture sessions keep the body in high gear, and an onsite nutritionist offers nutrition tips developed by registered dietitian Amy Boyce.


text:
Rafael Payare
Music Director
Rafael Payare has been Chief Conductor of the Ulster Orchestra since September 2014 and Principal Conductor of the Castleton Festival in Virginia (succeeding the late Lorin Maazel) since July 2015. In 2016, the Ulster Orchestra cemented its relationship with Maestro Payare by appointing him Music Director.
Developing into one of the most sought after young conductors, he has made recent debuts with the Vienna Philharmonic, Munich Philharmonic, London Symphony and the Chicago Symphony at the Ravinia Festival. Other highlights have included the City of Birmingham Symphony, Rotterdam Philharmonic, Seoul Philharmonic, Oslo Philharmonic, Gothenburg Symphony and the Los Angeles and Royal Stockholm Philharmonic orchestras. 14-15 also saw his acclaimed opera debut conducting Madame Butterfly at the Royal Swedish Opera in Stockholm. He has enjoyed collaborations with soloists including Jean-Yves Thibaudet, Nikolai Lugansky, Alisa Weilerstein, Elisabeth Leonskaja, Sergey Khachatryan, Jonathan Biss and Alexander Melnikov.
Highlights of Payare's 2015-16 season included the Philharmonia Orchestra at the Royal Festival Hall, NDR Sinfonieorchester Hamburg, Frankfurt Radio Symphony, Czech Philharmonic, Orchestre de la Suisse Romande, Zurich Opera Orchester and the Bamberg Symphony; as well as return visits to the Cincinnati Symphony, CBSO, Rotterdam and Oslo Philharmonic orchestras.
In July 2012, Payare was personally invited by his mentor, the late Lorin Maazel, to conduct at his Castleton Festival in Virginia. This led to a close association and he was recently honoured to accept the position of Principal Conductor and returned to Castleton in July 2015 to conduct performances of Gounod 'Romeo and Juliette' and Beethoven Symphony No 9. He also enjoys a close relationship with the celebrated Polish composer, Krzysztof Penderecki, who invited Rafael to conduct part of his 80th birthday concerts in Warsaw, alongside such conductors as Valery Gergiev, Charles Dutoit, Leonard Slatkin and Jiri Belohlavek.
Born in 1980 and a graduate of the celebrated El Sistema in Venezuela, Payare began his formal conducting studies in 2004 with José Antonio Abreu and has conducted all the major orchestras in Venezuela, including the Simón Bolívar Orchestra, both in Caracas and in Toronto as part of their 2009 Canadian tour. Having also served as Principal Horn of the Simon Bolivar Orchestra, he took part in many prestigious tours and recordings with conductors including Giuseppe Sinopoli, Claudio Abbado, Sir Simon Rattle and Lorin Maazel. As an assistant conductor, he has worked under Claudio Abbado for his performance of Tchaikovsky's Sixth Symphony with the Simón Bolívar Orchestra and in September 2012 was invited by Daniel Barenboim to assist on his production of Siegfried at the Berlin Staatsoper. In May 2012 he was awarded first prize at the Malko International Conducting Competition.
With the Ulster Orchestra, as well as continuing their Beethoven and Tchaikovsky cycle and exploring a variety of repertoire, Rafael will lead the players in a busy schedule of education and outreach projects in Belfast and throughout Northern Ireland.


text:
covergirl introduces the capitol collection.
|{district 1}
- flamed up mega curl mascara (4 shades)
- capitol collection glosstinis (9 shades)
- capitol collection nail stickers (6 patterns)
- lipslicks smoochies sizzle gloss (6 shades)
the brand's capitol makeup artist, dotti, has created 12 distinct looks with the product line and existing covergirl products to depict all 12 districts from the story. featured here are a sampling of my favorite looks. to see all the looks visit capitol beauty studio. the 2nd movie, catching fire, is in theaters november 22.
|{district 3}
|{district 10}